neoplasm
|
• average cancer free survival is greater than 52 weeks and 2 of 9 mice develop pancreatic ductal adenocarcinoma
(J:116130)
• 2 of 11 mutants show evidence of pancreatic ductal adenocarcinoma at 6 months of age, but not at earlier times
(J:164210)
|
|
• pancreatic ductal lesions are seen at 9, 12, 18, and 26 weeks of are, similar to human pancreatic intraepithelial neoplasias (PanINs)
(J:87196)
• PanINs increase in number and size with age, however no invasive tumors are seen up to 30 weeks of age
(J:87196)
• no evidence of neoplasia in the acinar cell compartment, however focal reactive metaplastic changes are seen
(J:87196)
• low-grade mPanIN lesions are seen in 3 month old mutants and by 6 months of age, most mice exhibit mPanIN lesions
(J:164210)
|
endocrine/exocrine glands
|
• pancreatic islets are moderately enlarged but do not show evidence of neoplasia
|
|
• average cancer free survival is greater than 52 weeks and 2 of 9 mice develop pancreatic ductal adenocarcinoma
(J:116130)
• 2 of 11 mutants show evidence of pancreatic ductal adenocarcinoma at 6 months of age, but not at earlier times
(J:164210)
|
|
• pancreatic ductal lesions are seen at 9, 12, 18, and 26 weeks of are, similar to human pancreatic intraepithelial neoplasias (PanINs)
(J:87196)
• PanINs increase in number and size with age, however no invasive tumors are seen up to 30 weeks of age
(J:87196)
• no evidence of neoplasia in the acinar cell compartment, however focal reactive metaplastic changes are seen
(J:87196)
• low-grade mPanIN lesions are seen in 3 month old mutants and by 6 months of age, most mice exhibit mPanIN lesions
(J:164210)
|
|
• acinar-to-ductal metaplasia is seen at 1 week of age
|
growth/size/body
|
• most mutants exhibit abdominal distention due to ascites fluid and pancreatic enlargement
|
homeostasis/metabolism


Analysis Tools